Anthropic Uses Claude to Develop Its Own Experimental Drugs
Anthropic has revealed it is using Claude to develop its own experimental drugs targeting rare pediatric diseases and multiple cancers, marking the first time a frontier AI company has publicly announced its own drug pipeline.
2026-10-28 ~ 2026-10-28 · 2 related posts
- Anthropic reveals it is developing its own experimental drugs using Claude, targeting rare childhood diseases and cancers — Polymarket · 2026-10-28
- Anthropic reveals it is developing its own experimental drugs using Claude — Polymarket · 2026-10-28